DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 088292
The generic ingredient in IMIPRAMINE HYDROCHLORIDE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
Summary for 088292
Tradename: | IMIPRAMINE HYDROCHLORIDE |
Applicant: | Par Pharm |
Ingredient: | imipramine hydrochloride |
Patents: | 0 |
Therapeutic Class: | Antidepressants |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 088292
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 088292 | ANDA | KAISER FOUNDATION HOSPITALS | 0179-0118 | N | 0179-0118-70 |
IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 088292 | ANDA | Par Pharmaceutical, Inc. | 49884-054 | N | 49884-054-10 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Oct 21, 1983 | TE: | AB | RLD: | No |
Complete Access Available with Subscription